Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_assertion description "[We describe two non-small-cell lung cancer (NSCLC) patients in which treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs) gefitinib produced a prolonged control of bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_assertion evidence source_evidence_literature NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_assertion SIO_000772 18079016 NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_assertion wasDerivedFrom befree-20150227 NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_assertion wasGeneratedBy ECO_0000203 NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP368342.RAM1yB_FEq8UJI9X39VzTRQd6r0xlH8RzQ0jMEYhCO6FQ130_provenance.